BPT-958

N/A

Report date: 2025/01/14 15:33:30
NME

Base Information

Drug NameBPT-958
Drug Alias NameBPT958BPT-958
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAnti-PD-1Interleukin 18 modulators
TargetsProgrammed cell death protein 1Interleukin 18
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBright Peak Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesBright Peak Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A